Cover Image
市場調查報告書

全球經導管主動脈瓣置換術 (TAVR) 市場

Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook 2018-2022

出版商 Koncept Analytics 商品編碼 295729
出版日期 內容資訊 英文 91 Pages
訂單完成後即時交付
價格
Back to Top
全球經導管主動脈瓣置換術 (TAVR) 市場 Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook 2018-2022
出版日期: 2018年03月01日 內容資訊: 英文 91 Pages
簡介

提供本報告提供全球TAVR市場相關調查分析,美國和歐洲等主要市場為焦點,主要趨勢,推動因素和課題相關驗證,競爭情形,企業簡介等。

第1章 簡介

第2章 全球市場分析

  • 全球市場:以金額為準
  • 市場預測:以金額為準
  • 全球市場:植入數為準
  • 市場預測:植入數的預測
  • 患者數
  • 患者數的預測

第3章 各地區市場

  • 美國
  • 美國以外
    • 美國以外的市場
    • 歐洲市場

第4章 市場趨勢

  • 成長推動因素
  • 主要趨勢
  • 課題

第5章 競爭情形

  • 全球市場
  • 美國
  • 美國以外

第6章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Transcatheter aortic valve implantation (TAVI) is a relatively new technology in the field of medical science. It is a minimally invasive surgery of replacing heart valve without undergoing the conventional by-pass surgery. It has emerged as one of the most feasible alternatives to conventional surgical aortic valve replacement. Transcatheter aortic valve implantation is also sometimes called as Transcatheter Aortic Valve Replacement (TAVR). The transcatheter aortic valve replacement market has gained popularity as a treatment option for those who are too weak to undergo surgery or are at high risk.

There are multiple approaches for TAVI procedure which includes transfemoral, transapical and transaortic approach. TAVI uses a catheter to replace the heart valve instead of the opening of the chest and completely removing the diseased valve. The TAVI valve is implanted within the diseased aortic valve. The valve is compressed onto the balloon that is expanded, pushing the leaflets of the diseased valve outside and when balloon deflated, the valve begins working instantly. This technique is still in its early stages but is growing rapidly through observational studies and randomized clinical trials.

The global TAVI market is expected to grow in future due to increasing ageing population, rising healthcare expenditure, increasing obese population, global economic development and increasing prevalence of inoperable aortic stenosis. Key trends in this market include rising demand for minimally invasive procedures, strong research and development efforts, rising mergers, technological advancements, favorable reimbursement policies, new product launch and TAVI for low-risk patients. However, the growth of this market will be hindered by stringent regulations, high cost of TAVI devices and high risks associated with the TAVI procedure.

The report "Global TAVI Market: Industry Analysis & Outlook (2018-2022)" analyses the development of this market, with focus on the U.S and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and Abbott Laboratories are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVI market along with the study of the regional markets.

Table of Contents

1. Market Overview

  • 1.1 Aortic Stenosis
  • 1.2 Transcatheter Aortic Valve Implantation (TAVI)
  • 1.3 TAVI Procedure
  • 1.4 Approaches to TAVI Procedure
  • 1.5 Benefits and Risk Associated with TAVI Procedure

2. Global Market Analysis

  • 2.1 Global TAVI Market by Value
  • 2.2 Global TAVI Market Forecast by Value
  • 2.3 Global TAVI Implant Volume
  • 2.4 Global TAVI Implant Volume Forecast
  • 2.5 Global TAVI Patient Population
  • 2.6 Global TAVI Patient Population Forecast
  • 2.7 TAVI Market by Region

3. Regional Market Analysis

  • 3.1 The U.S.
    • 3.1.1 The U.S. TAVI Market by Value
    • 3.1.2 The U.S. TAVI Market Forecast by Value
    • 3.1.3 The U.S. TAVI Implant Volume
    • 3.1.4 The U.S. TAVI Implant Volume Forecast
    • 3.1.5 The U.S. TAVI Implant Volume by Patient Type
    • 3.1.6 The U.S. TAVI Implant Volume Forecast- Patient Type
    • 3.1.7 The U.S. TAVI Implant Volume by Access Route
    • 3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
  • 3.2 Outside the U.S.
    • 3.2.1 OUS TAVI Market by Value
    • 3.2.2 OUS TAVI Market Forecast by Value
    • 3.2.3 OUS TAVI Implant Volume
    • 3.2.4 OUS TAVI Implant Forecast by Volume
    • 3.2.5 OUS TAVI Patient Population
    • 3.2.6 OUS TAVI Patient Population Forecast
    • 3.2.7 Europe TAVI Implant Volume by Patient Type
    • 3.2.8 Europe TAVI Implant Volume Forecast by Patient Type
    • 3.2.9 Europe TAVI Implant Volume by Access Route

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Growing Ageing Population
    • 4.1.2 Escalating Healthcare Spending
    • 4.1.3 Rising GDP Per Capita
    • 4.1.4 Increase in Obese Population
    • 4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
  • 4.2 Key Trends & Development
    • 4.2.1 Strong Research & Development Efforts by Companies
    • 4.2.2 Rising Mergers and Acquisitions
    • 4.2.3 Growing Adoption of Minimally Invasive Therapies
    • 4.2.4 Recent Technological Advancements
    • 4.2.5 Burden of Cardiovascular Diseases in the U.S.
    • 4.2.6 Favorable Reimbursement Policies
    • 4.2.7 TAVI for Low Risk Patients
    • 4.2.8 New Product Launches
  • 4.3 Challenges
    • 4.3.1 Associated High Risk
    • 4.3.2 Tough Regulatory Problems
    • 4.3.3 High Cost Related to TAVI

5. Competition

  • 5.1 Global Market
    • 5.1.1 Revenue and Market Cap Comparison
    • 5.1.2 Global TAVI Market Share by Company
    • 5.1.3 Global TAVI Market-Implanting Centers by Company
    • 5.1.4 Global TAVI Market- Total Implants by Company
    • 5.1.5 Global TAVI Market- Average Selling Price of Implants by Company
  • 5.2 The U.S.
    • 5.2.1 The U.S. TAVI Market Share by Company
    • 5.2.2 The U.S. TAVI Market-Implanting Centers by Company
    • 5.2.3 The U.S. TAVI Market-Total Implants by Company
    • 5.2.4 The U.S. TAVI Market-Average Selling Price of Implants by Company
  • 5.3 Outside the U.S.
    • 5.3.1 OUS TAVI Market Share by Company
    • 5.3.2 OUS TAVI Market-Implanting Centers by Company
    • 5.3.3 OUS TAVI Market-Total Implants by Company
    • 5.3.4 OUS TAVI Market-Average Selling Price of Implants by Company

6. Company Profiles

  • 6.1 Edwards Lifesciences
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Medtronic Plc.
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Boston Scientific
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Abbott Laboratories
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Approaches to TAVI Procedure
  • Global TAVI Market by Value (2013-2017)
  • Global TAVI Market Forecast by Value (2018-2022)
  • Global TAVI Implant Volume (2013-2017)
  • Global TAVI Implant Volume Forecast (2018-2022)
  • Global TAVI Patient Population (2013-2017)
  • Global TAVI Patient Population Forecast (2018-2022)
  • TAVI Market by Region (2017)
  • The U.S. TAVI Market by Value (2013-2017)
  • The U.S. TAVI Market Forecast by Value (2018-2022)
  • The U.S. TAVI Implant Volume (2013-2017)
  • The U.S. TAVI Implant Volume Forecast (2018-2022)
  • The U.S. TAVI Implant Volume by Patient Type (2017)
  • The U.S. TAVI Implant Volume Forecast- Patient Type (2018-2022)
  • The U.S. TAVI Implant Volume by Access Route (2017)
  • The U.S. Aortic Valve Disease Patient Population Forecast (2017-2022)
  • OUS TAVI Market by Value (2013-2017)
  • OUS TAVI Market Forecast by Value (2018-2022)
  • OUS TAVI Implant Volume (2013-2017)
  • OUS TAVI Implant Forecast by Volume (2018-2022)
  • OUS TAVI Patient Population (2013-2017)
  • OUS TAVI Patient Population Forecast (2018-2022)
  • Europe TAVI Implant Volume by Patient Type (2017)
  • Europe TAVI Implant Volume Forecast by Patient Type (2018-2022)
  • Europe TAVI Implant Volume by Access Route (2017)
  • Global Ageing Population (2013-2017)
  • Global Healthcare Spending Per Capita (2013-2017)
  • Global GDP Per Capita (2013-2017)
  • Global Obese Population (2013-2017)
  • Burden of Cardiovascular Diseases in the U.S. (2017)
  • Key Players - Revenue & Market Cap Comparison (2017)
  • Global TAVI Market Share by Company (2017/2022)
  • Global TAVI Market- Implanting Centers by Company (2017-2022)
  • Global TAVI Market- Total Implants by Company (2017-2022)
  • Global TAVI Market- Average Selling Price of Implants by Company (2017-2022)
  • The U.S. TAVI Market Share by Company (2017/2022)
  • The U.S. TAVI Market-Implanting Centers by Company (2017-2022)
  • The U.S. TAVI Market-Total Implants by Company (2017-2022)
  • The U.S. TAVI Market-Average Selling Price of Implants by Company (2017-2022)
  • OUS TAVI Market Share by Company (2017/2022)
  • OUS TAVI Market-Implanting Centers by Company (2017-2022)
  • OUS TAVI Market-Total Implants by Company (2017-2022)
  • OUS TAVI Market-Average Selling Price of Implants by Company (2017-2022)
  • Edwards Lifesciences Corporation Revenue by Segments (2017)
  • Edwards Lifesciences Net Sales and Net Income (2013-2017)
  • Edwards Lifesciences R&D Expenditure (2015-2017)
  • Medtronic Plc. Revenue by Segments (2017*)
  • Medtronic Plc. Net Sales and Net Income (2013-2017*)
  • Boston Scientific Revenue by Segments (2017)
  • Boston Scientific Revenue and Net Income (2013-2017)
  • Boston Scientific R&D Expenditure (2015-2017)
  • Abbott Laboratories Revenue by Segments (2017)
  • Abbott Laboratories Net Sales and Net Earnings (2013-2017)
  • Abbott Laboratories R&D Expenditure (2015-2017)

List of Tables

  • R&D Expenditure of Companies (2017)
  • Mergers and Acquisitions (2017)
Back to Top